28 results on '"Ferreiro, Julio Finalet"'
Search Results
2. Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
3. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma
4. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy
5. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
6. Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.
7. Genomic alterations of theJAK2andPDLloci occur in a broad spectrum of lymphoid malignancies
8. Pulmonary transcriptome analysis in the rabbit model of surgically-induced diaphragmatic hernia treated with fetal tracheal occlusion
9. Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL
10. Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1
11. BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma
12. Rearrangement of NOTCH1 or BCL3 can independently trigger progression of CLL
13. Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes
14. BMI1, the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma.
15. BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma
16. Genomic Alterations of the JAK2 and PDL Loci Occur in a Broad Spectrum of Lymphoid Malignancies.
17. Non-IG Aberrations of FOXP1 in B-Cell Malignancies Result in an Aberrant Expression of N-Truncated FOXP1 Isoforms.
18. Biallelic inactivation of NF1 in a sporadic plexiform neurofibroma
19. Recurrent breakpoints in 14q32.13/TCL1Aregion in mature B-cell neoplasms with villous lymphocytes
20. JAK2, As Well As PDL1 and PDL2, are Recurrently Targeted by 9p24 Structural and Numerical Aberrations in Lymphoid Neoplasms of Both B- and T-Cell Origin
21. T(X;14)(p11.4;q32.33) Is Recurrent In Marginal Zone Lymphoma and Upregulates GPR34
22. BMI1, the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma.
23. Recurrent breakpoints in 14q32.13/ TCL1A region in mature B-cell neoplasms with villous lymphocytes.
24. Rearrangement of NOTCH1or BCL3can independently trigger progression of CLL
25. Non-IGAberrations of FOXP1in B-Cell Malignancies Result in an Aberrant Expression of N-Truncated FOXP1 Isoforms.
26. JAK2, As Well As PDL1and PDL2, are Recurrently Targeted by 9p24 Structural and Numerical Aberrations in Lymphoid Neoplasms of Both B- and T-Cell Origin
27. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.
28. Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.